Progress in understanding the molecular pathogenesis of human lung cancer

被引:145
作者
Sekido, Y [1 ]
Fong, KM [1 ]
Minna, JD [1 ]
机构
[1] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75235 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 1998年 / 1378卷 / 01期
关键词
lung cancer; smoking; prognosis; early detection; prevention; preneoplasia; dominant oncogene; recessive oncogene; tumor suppressor gene; signal transduction; apoptosis; cell cycle; microsatellite alteration; TP53; RB; p16; telomerase; 3p; RAS; MYC; BCL2; autocrine; paracrine; angiogenesis; anergy;
D O I
10.1016/S0304-419X(98)00010-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We review the molecular pathogenesis of lung cancer including alterations in dominant oncogenes, recessive oncogenes/tumor suppressor genes, alterations in growth regulatory signaling pathways, abnormalities in other pathways, such as apoptosis, autocrine and paracrine growth stimulatory loops, angiogenesis, and host immune responses, other mechanisms of genetic changes, such as microsatellite and methylation alterations, and the potential for inherited predisposition to lung cancer. These changes are related to multistage carcinogenesis involving preneoplastic lesions, and lung development and differentiation. The translational applications of these findings for developing new ways of early detection, prevention, treatment, and prognosis of lung cancer are discussed. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:F21 / F59
页数:39
相关论文
共 341 条
[1]   MICROSATELLITE INSTABILITY IN PRIMARY AND METASTATIC LUNG CARCINOMAS [J].
ADACHI, J ;
SHISEKI, M ;
OKAZAKI, T ;
ISHIMARU, G ;
NOGUCHI, M ;
HIROHASHI, S ;
YOKOTA, J .
GENES CHROMOSOMES & CANCER, 1995, 14 (04) :301-306
[2]  
Adachi J, 1996, CELL GROWTH DIFFER, V7, P879
[3]   High telomerase activity in primary lung cancers: Association with increased cell proliferation rates and advanced pathologic stage [J].
Albanell, J ;
Lonardo, F ;
Rusch, V ;
Engelhardt, M ;
Langenfeld, J ;
Han, W ;
Klimstra, D ;
Venkatraman, E ;
Moore, MAS ;
Dmitrovsky, E .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (21) :1609-1615
[4]   The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions [J].
Alroy, I ;
Yarden, Y .
FEBS LETTERS, 1997, 410 (01) :83-86
[5]  
Angeletti CA, 1996, CANCER-AM CANCER SOC, V78, P409, DOI 10.1002/(SICI)1097-0142(19960801)78:3<409::AID-CNCR5>3.0.CO
[6]  
2-E
[7]   MALIGNANT EPITHELIAL-CELLS IN PRIMARY HUMAN LUNG CARCINOMAS COEXPRESS INVIVO PLATELET-DERIVED GROWTH-FACTOR (PDGF) AND PDGF RECEPTOR MESSENGER-RNAS AND THEIR PROTEIN PRODUCTS [J].
ANTONIADES, HN ;
GALANOPOULOS, T ;
NEVILLEGOLDEN, J ;
OHARA, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3942-3946
[8]   Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer [J].
Apolinario, RM ;
vanderValk, P ;
deJong, JS ;
Deville, W ;
vanArkOtte, J ;
Dingemans, AMC ;
vanMourik, JC ;
Postmus, PE ;
Pinedo, HM ;
Giaccone, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2456-2466
[9]   Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases [J].
Arenberg, DA ;
Kunkel, SL ;
Polverini, PJ ;
Morris, SB ;
Burdick, MD ;
Glass, MC ;
Taub, DT ;
Iannettoni, MD ;
Whyte, TI ;
Strieter, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :981-992
[10]   Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice [J].
Arenberg, DA ;
Kunkel, SL ;
Polverini, PJ ;
Glass, M ;
Burdick, MD ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2792-2802